Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke

E-ISSN： 1873-4286|23|9|1377-1391

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.9, 2017-04, pp. : 1377-1391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet and Anticoagulation Strategies in the Prevention and Treatment of Ischemic Stroke

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5261-5272

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Antiplatelet Agents Used in the Secondary Prevention of Stroke

By Lenz T.L. Wilson A.F.

Clinical Pharmacokinetics, Vol. 42, Iss. 10, 2003-01 ,pp. : 909-920

Adis International

Access to resources Recommend Favorite

Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies

Current Pharmaceutical Design, Vol. 23, Iss. 9, 2017-04 ,pp. : 1406-1423

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Treatment in Ischemic Stroke Treatment

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 14, 2009-10 ,pp. : 1298-1316

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet therapy in secondary stroke prevention

By Crawford K Michelle Talbert Robert L

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1609-1613

Informa Healthcare

Access to resources Recommend Favorite